medroxyprogesterone has been researched along with norethindrone acetate in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (60.87) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 1 (4.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuhl, H; Pietzsch, V | 1 |
LaRosa, JC; Miller, VT; Muesing, RA; Phillips, EA; Stillman, RJ; Stoy, DB | 1 |
Meyer, JE; Ravnikar, VA; Stomper, PC; Van Voorhis, BJ | 1 |
Dören, M; Montag, M; Schneider, HP | 1 |
Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
Mishell, DR | 1 |
Amatayakul, K; Suriyanon, V | 1 |
Carpenter, JT | 1 |
Griesinger, R; Schindler, AE | 1 |
Guerin, JF; Rollet, J | 1 |
Belsey, EM | 1 |
Fraser, IS | 1 |
Flowers, CE; Hyde, BM; Wilborn, WH | 1 |
Castaneda, TA; Gambrell, RD; Massey, FM; Ricci, CA; Ugenas, AJ; Wright, JM | 1 |
Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 2 |
Orpana, A; Puolakka, J; Pyörälä, T; Viinikka, L; Ylikorkala, O | 1 |
Lübbert, H; Nauert, C | 1 |
Andersen, LF; Gram, J; Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 1 |
Alessandrini, C; Arangino, S; Baldassari, F; Cagnacci, A; Landi, S; Volpe, A | 1 |
Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T | 1 |
Bernstein, P; Pohost, G | 1 |
3 review(s) available for medroxyprogesterone and norethindrone acetate
Article | Year |
---|---|
Progestational agents in the treatment of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins | 1988 |
Long acting injectable hormonal contraceptives.
Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms | 1982 |
Progesterone, progestins, and the heart.
Topics: Coronary Vessels; Estrogen Replacement Therapy; Humans; Medroxyprogesterone; Myocardial Infarction; Myocardium; Norethindrone; Norethindrone Acetate; Patient Selection; Progesterone; Progestins; Risk Assessment; Risk Factors; Stroke; Women's Health | 2010 |
8 trial(s) available for medroxyprogesterone and norethindrone acetate
Article | Year |
---|---|
Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Sex Hormone-Binding Globulin | 1991 |
[Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Prospective Studies | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2.
Topics: Administration, Cutaneous; Administration, Oral; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Thromboxane A2 | 1997 |
Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Body Weight; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Uterine Hemorrhage | 1997 |
A comparison of the central effects of different progestins used in hormone replacement therapy.
Topics: Administration, Cutaneous; Anxiety; Body Temperature; Depression; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Placebos; Postmenopause; Progestins; Time Factors | 2004 |
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause | 2005 |
12 other study(ies) available for medroxyprogesterone and norethindrone acetate
Article | Year |
---|---|
[Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Protein Binding; Testosterone | 1991 |
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.
Topics: Adult; Aged; Breast; Delayed-Action Preparations; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Retrospective Studies; X-Ray Intensifying Screens | 1990 |
Use of progestins.
Topics: Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Time Factors | 1989 |
The effects of long-acting injectable contraceptives on carbohydrate metabolism.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Longitudinal Studies; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pyruvates; Time Factors | 1985 |
[Therapy with gestagens in hyperplastic changes of the endometrium].
Topics: Adenocarcinoma; Adenoma; Endometrial Hyperplasia; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norethindrone Acetate; Uterine Neoplasms | 1986 |
Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Topics: Administration, Cutaneous; Adult; Contraceptive Agents, Male; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Sperm Count; Spermatogenesis; Testosterone | 1988 |
Facts about injectable contraceptives: memorandum from a WHO meeting.
Topics: Animals; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnancy; World Health Organization | 1982 |
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage | 1983 |
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Precancerous Conditions; Progesterone; Prospective Studies; Risk; Uterine Neoplasms | 1980 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Topics: Adult; Blood Glucose; Castration; Contraceptives, Oral, Combined; Female; Glucose Tolerance Test; Humans; Hysterectomy; Insulin; Levonorgestrel; Lipids; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Cervical Neoplasms | 1982 |
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Osmolar Concentration; Postmenopause; Progesterone Congeners; Progestins; Reference Values | 2002 |